The survival analysis using log‐rank test indicated the lower recurrence free survival for patients with low expression of SMARCA2 gene (Figure 3c) p‐value = .0217 and the overall survival was significantly lower for BC patients with low expression of BRM encoding gene—SMARCA2 (Figure 3d). Here, SMARCA2 is linked to breast cancer.